In biotech, success often hinges on spotting opportunities before anyone else does. Some of the industry’s most impactful companies have been built with smart business development regardless of their R&D bench that transforms their companies by advancing them into the next drug development stage, expanding their therapeutic areas to pursue other commercial markets, and creating favorable long-term financial positions. Hear from panelists who have made well-timed decisions, identified overlooked assets and in-licensing programs, and transformed them into successes with great science, grit, and a dedicated team. This panel will explore the art and science of intelligent business development, deals that are creative, how to recognize overlooked value, structure deals that create long-term growth, and build organizations around in-licensed innovation. Hear from leaders who turned unknown companies into industry players through sharp judgment, strategic vision, and a willingness to take calculated risks.